Please Wait
Applying Filters...
menu
    • menu
    BMS, J&J, Bayer lead 25,000+ pharma layoffs in 2024; Amylyx, FibroGen, Kronos Bio hit by trial failures, cash crunch

    Data Compilation
    #PharmaFlow

    Pipeline Prospector 2024 highlights: Rise in new breed of biotechs with maiden approvals; GLP-1 meds show promise beyond obesity

    Stock Recap
    #PipelineProspector

    Menu

    Manidipine Dihydrochloride

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,509Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    30/12/2024 Jeil Pharmaceutical Co., Ltd
    South Korea
    		 JEIL PHARMACEUTICAL CO. , LTD. 306MF10077 Manidipine Hydrochloride 2024-06-12 2024-06-12 343, Sapyeong-daero, Seocho-gu, Seoul, Korea
    30/12/2024 Jeil Pharmaceutical Co., Ltd
    South Korea
    		 JEIL PHARMACEUTICAL CO. , LTD. 217MF10410 Manidipine hydrochloride 2005-08-19 2006-06-09 343, Sapyeong-daero, Seocho-gu, Seoul, Korea